New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM 87106, USA.
J Clin Densitom. 2011 Jan-Mar;14(1):1-21. doi: 10.1016/j.jocd.2010.12.001.
The 11th Santa Fe Bone Symposium was held in Santa Fe, NM, USA, on August 6-7, 2010. This annual event addresses clinically relevant advances in the fields of osteoporosis and metabolic bone disease. The venue includes plenary presentations by internationally recognized experts, oral presentations of abstracts, and interactive panel discussions of challenging cases and controversial issues. Attendees are active participants throughout the symposium program. Topics for the 2010 symposium included potential applications of novel technologies for the assessment of skeletal health for research and clinical practice; new and emerging treatments for osteoporosis; appropriate use of pharmacological agents to prevent osteoporosis; controversies with bisphosphonate therapy; practical applications of the World Health Organization fracture risk assessment tool (FRAX; World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK); insights into the use of osteoanabolic agents to enhance fracture healing; and challenges in laboratory testing in the assessment of factors contributing to skeletal fragility. Concurrent sessions focused on critical thinking for technologists in the acquisition and analysis of data with dual-energy X-ray absorptiometry. The key messages from each presentation, including the best available medical evidence and potential current and future clinical applications, are provided here.
第十一届圣达菲骨研讨会于 2010 年 8 月 6 日至 7 日在美国新墨西哥州圣达菲举行。这一年度活动针对骨质疏松症和代谢性骨病领域的临床相关进展。会议场地包括国际知名专家的全体会议演讲、摘要口头报告，以及具有挑战性病例和争议性问题的互动小组讨论。与会者是整个研讨会计划的积极参与者。2010 年研讨会的主题包括评估骨骼健康的新技术在研究和临床实践中的潜在应用；骨质疏松症的新出现和新兴治疗方法；预防骨质疏松症的药物的合理使用；双膦酸盐治疗的争议；世界卫生组织骨折风险评估工具（FRAX；世界卫生组织代谢性骨疾病合作中心，英国谢菲尔德大学）的实际应用；了解骨合成代谢药物在增强骨折愈合中的应用；以及在评估导致骨骼脆弱性的因素的实验室测试中面临的挑战。同期会议侧重于技术人员在使用双能 X 射线吸收仪获取和分析数据时的批判性思维。这里提供了每个演讲的关键信息，包括最佳的现有医学证据以及潜在的当前和未来临床应用。
